Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
PHASE2CompletedINTERVENTIONAL
Enrollment
18
Participants
Timeline
Start Date
September 30, 2020
Primary Completion Date
February 15, 2022
Study Completion Date
February 15, 2022
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG
Dorzagliatin
tablet
DRUG
placebo
placebo
Trial Locations (1)
Unknown
The Chinese University of Hong Kong, Hong Kong
All Listed Sponsors
lead
Chinese University of Hong Kong
OTHER
NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes | Biotech Hunter | Biotech Hunter